ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 660841 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 660841; 2) Community: the network communities that were significantly associated with the response to NSC 660841; 3) Molecule: the relationships between components within communities and NSC 660841; 4) MDR: the compounds that were significantly associated with the NSC 660841.

NSC Compound Enrichment Correlation
NSC 667088 Null 0.029142074732756 0.22697344
NSC 673597 Null 0.029142074732756 0.35785185
NSC 674103 2-Acetylimidazo[4,5-b]pyridin 4 p-chlorophenyl 3 thiosemicarbazone 0.029142074732756 0.19363827
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.029142074732756 0.21141063
NSC 696073 Null 0.029142074732756 0.2000207
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.029142074732756 0.52639502
NSC 710326 Null 0.029142074732756 0.31418818
NSC 718630 Null 0.029142074732756 0.43986353
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.029142074732756 0.133526
NSC 726217 Combretastatin A4-analogue 0.029142074732756 0.2266892
Total:113  Current:84    [First] [Prev] [Next] [Last]